We offer guidance on comparability testing and preparation of non-clinical and clinical documentation, as required per Article 10(4) of Directive 2001/83/EC for the licensing of biosimilar medicinal products. Our experts can assist you in the registration phase,
as well as in the post-marketing phase by managing the product’s pharmacovigilance.